Free Trial
→ A grave, grave error. (From Porter & Company) (Ad) Buy TVTX Stock  Free TVTX Stock Alerts

Travere Therapeutics (TVTX) SEC Filings & 10K Form

Travere Therapeutics logo
$15.84 +0.14 (+0.89%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$15.92 +0.07 (+0.47%)
As of 05/23/2025 07:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Travere Therapeutics SEC Filings

Export to Excel
DateFilerForm TypeView
05/16/2025
6:00 PM		Orwin John A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Baynes Roy D. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Bruhn Suzanne Louise (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		COUGHLIN TIMOTHY (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		LYONS GARY A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Poole Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Squarer Ron (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2025
6:00 PM		Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Williams Brinkley Ruth (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2025
2:13 PM		ARMISTICE CAPITAL, LLC (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G/A
05/15/2025
9:47 AM		Rock Springs Capital Management LP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G/A
05/15/2025
5:18 AM		MACQUARIE GROUP LTD (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G/A
05/14/2025
10:48 AM		JANUS HENDERSON GROUP PLC (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G
05/05/2025
8:51 PM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
8:52 PM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
8:53 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
8:53 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
8:54 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
6:41 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
6:45 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
10:32 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
10:20 AM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/05/2025
9:08 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/01/2025
4:21 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K/A
04/14/2025
5:23 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/11/2025
6:03 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/17/2025
3:57 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
7:36 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/14/2025
8:10 AM		Rock Springs Capital Management LP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G/A
02/12/2025
8:27 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:28 PM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:30 PM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:22 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:23 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:25 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
6:46 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
6:47 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
10:03 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
8:52 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
10:56 AM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
6:05 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)

Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.

If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is
02/10/2025
5:04 PM		Baynes Roy D. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/07/2025
6:44 AM		MACQUARIE GROUP LTD (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G/A
02/05/2025
12:23 PM		BlackRock, Inc. (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SCHEDULE 13G/A
02/04/2025
7:30 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:30 PM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:30 PM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:30 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:30 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:30 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
7:30 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
7:40 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
7:41 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
7:46 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
7:47 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
11:26 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
10:11 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/03/2025
10:22 AM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
9:09 AM		Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
01/23/2025
7:35 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:36 PM		Baynes Roy D. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:37 PM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:39 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:40 PM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:31 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
7:33 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:14 PM		Baynes Roy D. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
9:34 AM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
9:18 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/22/2025
8:36 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:30 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2025
6:21 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2024
6:47 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/26/2024
3:13 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/25/2024
8:00 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2024
4:59 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/14/2024
8:46 AM		Deep Track Capital, LP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
11/08/2024
3:55 PM		MORGAN STANLEY (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
11/08/2024
3:11 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 424B5
11/04/2024
12:55 PM		Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/31/2024
7:36 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/31/2024
7:41 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 424B5
10/31/2024
7:05 AM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
10:59 AM		STATE STREET CORP (Filed by)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form SC 13G/A
10/04/2024
6:15 PM		LYONS GARY A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
7:38 PM		Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/30/2024
3:22 PM		Meckler Jeffrey A (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/11/2024
5:29 PM		Calvin Sandra (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/10/2024
3:05 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		Heerma Peter (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
Trump Exec Order 14179 is wealth “gift” to good Americans? (Ad)

Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve suffered financial hardship…Our President may have solved everything.

If you missed out on a bitcoin fortune, this could be your second chance. A brief “wealth window” is
09/09/2024
8:20 PM		Inrig Jula (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
8:20 PM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2024
9:54 AM		REED ELIZABETH E (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2024
9:34 AM		Dube Eric M (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/09/2024
9:35 AM		ROTE WILLIAM E. (Reporting)
Travere Therapeutics, Inc. (Subject)
Travere Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/05/2024
8:30 PM		Cline Christopher R. (Reporting)
Travere Therapeutics, Inc. (Issuer)
Travere Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
4:24 PM		Travere Therapeutics, Inc. (Filer)
Travere Therapeutics (Filer)
Form S-3ASR
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:TVTX) was last updated on 5/24/2025 by MarketBeat.com Staff
From Our Partners
Trump Predicts Dollar Downfall
READ THIS VERY CAREFULLY: If you have $100,000 or more saved for retirement, this may make you VERY angry... ...
Augusta Precious Metals | Sponsored
Trump Exec Order 14179 is wealth “gift” to good Americans?
Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...
Paradigm Press | Sponsored
White House to reset Social Security?
Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...
Altimetry | Sponsored
$19 for a FULL YEAR of stock picks?!
Invest in Musk's AI Play With Just $100 You don't need deep pockets to ride the next wave of AI wealth. ...
Behind the Markets | Sponsored
Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...
Brownstone Research | Sponsored
Gold Hits New Highs as Global Markets Spiral
When Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...
Premier Gold Co | Sponsored
The Hidden Energy Source Backed by Billionaires
Why Billionaires Have Set Their Sights on the Utah Desert Something strange is happening near the Wah Wah ...
Stansberry Research | Sponsored
After Monday, price goes up 600% (hurry)
Right now, for a limited time… You can get up to 52 Money Monday trades for just $7! Thanks to Wall Street’...
Timothy Sykes | Sponsored